Anondita Medicare IPO Details
| Detail | Description |
|---|---|
| IPO Date | August 22, 2025 to August 26, 2025 |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Issue Price Band | ₹ 137 to ₹ 145 per share |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 47,93,000 shares (aggregating up to ₹ 69.50 Cr) |
| Reserved for Market Maker | 2,70,000 shares (aggregating up to ₹ 3.92 Cr) Mansi Share & Stock Broking Pvt.Ltd. |
| Net Offered to Public | 45,23,000 shares (aggregating up to ₹ 65.58 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,32,93,618 shares |
| Share Holding Post Issue | 1,80,86,618 shares |
About Anondita Medicare IPO
Anondita Medicare IPO is a plan to raise funds by issuing 100% book-built or NSE Emerge. A total of up to 47,93,000 fresh equity shares worth ₹10 each will be issued with the IPO. In this offer, all proceeds go to Anondita Medicare Limited. Category allocation follows SME norms, with a maximum of 50% reserved for QIBs, at least 15% NIIs and no more than 35% left for Retail. The proposed application window is 22–26 August 2025, with the listing to be done on the NSE Emerge platform. The company is looking to raise around ₹69.50 crore via this IPO route.
Company Background
Anondita Medicare Limited was incorporated on 12 March 2024 as a public company, after the business had previously run as a sole proprietor under M/s Anondita Healthcare, the Anupam Ghosh-promoted firm. Its registered office is at Vasant Kunj, New Delhi, where it has Operations in Noida (Uttar Pradesh). The company focuses on healthcare consumables for men, with a primary focus on male condoms. In addition, the company has direct technical capacity, regulatory processes and tender registrations through its legacy operations.
Operations & Product Range
Facility & Production
The company manufactures male condoms on automated manufacturing lines. The company’s process begins with compounding through immersing shapes into formers, vulcanizing them, washing, performing electronic tests and applying rubber lubrication. Then it goes into foil packing for safekeeping under medical device/healthcare compliance. Anondita highlights that it now has an installed capacity of 562 million condoms per annum, along with multiple high-speed lines at its Noida plant alone. It will also start production of disposable female condoms, according to the company. All the production conforms to applicable regulations or standards for healthcare consumables and the rubber industry.
Brands & Market Presence
Anondita manufactures and markets male condoms under its flagship brand “Cobra” in various flavours and textures for consumer retail, while also supplying to institutional buyers via tenders and public health programs. The company participates in domestic channels and select export markets and also undertakes private-label manufacturing for third-party brands.
Revenue Channels
- Institutional/government tenders as well as public health programs.
- Export sales to distributors and institutional buyers.
- Domestic sales to retailers, trade buyers and with its brands.
- Private-label as a third-party manufacturer for other brands.
Management & Shareholding
Promoters & Shareholding
The promoters of Anondita Medicare IPO are Mr. Anupam Ghosh, Mrs. Sonia Ghosh and Mr. Reshant Ghosh. The pre-issue promoter holding is around 83.95% and the post-issue of around 61.71%.
Board Members
The board structure follows SME listing norms with executive and independent directors.
Objectives of Anondita Medicare IPO
- Working capital augmentation for scale-up and tender cycles.
- Line upgrades, efficiency improvements and capacity balancing.
- Market development, certifications/registrations and export expansion.
- General corporate purposes and issue-related expenses.
Conclusion
Anondita Medicare’s IPO offers exposure to the healthcare consumables segment with core strength in condoms, supported by a mix of institutional demand and retail presence. By moving from proprietorship to a public company with a business transfer, the company ranks itself at higher governance levels and access to capital. The company has typical SME risks such as liquidity, tender-driven pricing, raw material prices and compliance requirements.
Anondita Medicare IPO Financial Information
Latest Revenue
77.13
₹ Crore
Profit After Tax
16.42
₹ Crore
Net Worth
37.87
₹ Crore
Total Borrowing
27.39
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 78.27 | 77.13 | 16.42 | 37.87 | 27.39 | ||||
| 31 Mar 2024 | 43 | 47 | 4 | 11 | 24.01 | ||||
| 31 Mar 2023 | 37.8 | 36.14 | 0.35 | 8.69 | 22.66 | ||||
| Amount in ₹ Crore | |||||||||
Anondita Medicare Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 41.71% |
| ROCE | 37.42% |
| Debt/Equity | 0.7 |
| RoNW | 41.71% |
| PAT Margin | 21.32% |
| EBITDA Margin | 33.32% |
| Price to Book Value | 15.07 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 12.35 | 9 |
| P/E (x) | 11.74 | 16 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
This is a focused manufacturer in the condom category with process control and a mature quality system.
Noida is the location for its state-of-the-art facility. The automated lines can also handle multiple variants of the product.
The company has a combination in its multi-channel model: tenders, exports, own brand and private label.
Legacy business relationships provided links to both domestic institutions and international business entities.
Download regulatory filings
Anondita Medicare IPO Timeline
| IPO Open Date | Fri, Aug 22, 2025 |
| IPO Close Date | Tue, Aug 26, 2025 |
| Tentative Allotment | Thu, Aug 28, 2025 |
| Initiation of Refunds | Fri, Aug 29, 2025 |
| Credit of Shares to Demat | Fri, Aug 29, 2025 |
| Tentative Listing Date | Mon, Sep 1, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on August 26, 2025 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2,000 | ₹2,90,000 |
| Individual investors (Retail) (Max) | 2 | 2,000 | ₹2,90,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,35,000 |
| S-HNI (Max) | 6 | 6,000 | ₹8,70,000 |
| B-HNI (Min) | 7 | 7,000 | ₹10,15,000 |